CGH
DPLO

Crossmark Global Holdings’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Crossmark Global Holdings’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17,830
Closed -$71K – 1398
2019
Q4 		$71K Buy
17,830
+10
+0.1% +$47 ﹤0.01% 1387
2019
Q3 		$87K Sell
17,820
-170
-0.9% -$951 ﹤0.01% 1334
2019
Q2 		$110K Buy
17,990
+130
+0.7% +$691 ﹤0.01% 1363
2019
Q1 		$104K Sell
17,860
-40
-0.2% -$413 ﹤0.01% 1371
2018
Q4 		$241K Sell
17,900
-2,380
-12% -$40.1K 0.01% 1200
2018
Q3 		$394K Buy
20,280
+1,150
+6% +$24.5K 0.01% 1128
2018
Q2 		$489K Buy
19,130
+400
+2% +$9.33K 0.01% 964
2018
Q1 		$377K Sell
18,730
-1,660
-8% -$38.7K 0.01% 1106
2017
Q4 		$409K Sell
20,390
-5,580
-21% -$110K 0.01% 1145
2017
Q3 		$538K Buy
+25,970
New +$439K 0.01% 910
2016
Q3 		$538K Buy
+25,970
New +$871K 0.01% 910

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Crossmark Global Holdings's DPLO Position: Q1 2020 in Review

Crossmark Global Holdings sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 17,830 shares — an estimated $71K sold.

Crossmark Global Holdings first reported a position in DPLO in Q3 2016 and held it in 11 quarters. The position peaked at $538K in Q3 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Crossmark Global Holdings reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Crossmark Global Holdings sold 17,830 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $71K.
  • Crossmark Global Holdings first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 11 quarters.
  • Crossmark Global Holdings's DIPLOMAT PHARMACY, INC. position peaked at $538K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Crossmark Global Holdings's 13F filing for Q1 2020, filed 28 Apr 2020.